The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Activation and allosteric modulation of a muscarinic acetylcholine receptor
Open accessAbstract
Despite recent advances in crystallography and the availability of G-protein-coupled receptor (GPCR) structures, little is known about the mechanism of their activation process, as only the β2 adrenergic receptor (β2AR) and rhodopsin have been crystallized in fully active conformations. Here we report the structure of an agonist-bound, active state of the human M2 muscarinic acetylcholine receptor stabilized by a G-protein mimetic camelid antibody fragment isolated by conformational selection using yeast surface display. In addition to the expected changes in the intracellular surface, the structure reveals larger conformational changes in the extracellular region and orthosteric binding site than observed in the active states of the β2AR and rhodopsin. We also report the structure of the M2 receptor simultaneously bound to the orthosteric agonist iperoxo and the positive allosteric modulator LY2119620. This structure reveals that LY2119620 recognizes a largely pre-formed binding site in the extracellular vestibule of the iperoxo-bound receptor, inducing a slight contraction of this outer binding pocket. These structures offer important insights into the activation mechanism and allosteric modulation of muscarinic receptors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
[20] Processing of X-ray diffraction data collected in oscillation mode
Otwinowski, Z., & Minor, W. (1997) · Methods in Enzymology · doi:10.1016/s0076-6879(97)76066-x · Cited by 33,475
Coot : model-building tools for molecular graphics
Emsley, P., & Cowtan, K. (2004) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444904019158 · Cited by 30,571
Colowick, S. P., Joshi, M. D., Jagannathan, & KAPLAN, N. O. (1966) · Cited by 26,137
Phaser crystallographic software
McCoy, A. J., Grosse-Kunstleve, R. W., Adams, P. D., Winn, M. D., Storoni, L. C., & Read, R. J. (2007) · Journal of Applied Crystallography · doi:10.1107/s0021889807021206 · Cited by 20,612
Towards automated crystallographic structure refinement with phenix.refine
Afonine, P. V., Grosse-Kunstleve, R. W., Echols, N., Headd, J. J., Moriarty, N. W., Mustyakimov, M., Terwilliger, T. C., Urzhumtsev, A., Zwart, P. H., & Adams, P. D. (2012) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444912001308 · Cited by 5,511
Crystal structure of the β2 adrenergic receptor–Gs protein complex
Rasmussen, S. G. F., DeVree, B. T., Zou, Y., Kruse, A. C., Chung, K. Y., Kobilka, T. S., Thian, F. S., Chae, P. S., Pardon, E., Calinski, D., et al. (2011) · Nature · doi:10.1038/nature10361 · Cited by 3,009
Self-citationStructure of a nanobody-stabilized active state of the β2 adrenoceptor
Rasmussen, S. G. F., Choi, H.-J., Fung, J. J., Pardon, E., Casarosa, P., Chae, P. S., DeVree, B. T., Rosenbaum, D. M., Thian, F. S., Kobilka, T. S., et al. (2011) · Nature · doi:10.1038/nature09648 · Cited by 1,680
Self-citationCrystal structure of opsin in its G-protein-interacting conformation
Scheerer, P., Park, J. H., Hildebrand, P. W., Kim, Y. J., Krauß, N., Choe, H.-W., Hofmann, K. P., & Ernst, O. P. (2008) · Nature · doi:10.1038/nature07330 · Cited by 1,059
Structure and dynamics of the M3 muscarinic acetylcholine receptor
Kruse, A. C., Hu, J., Pan, A. C., Arlow, D. H., Rosenbaum, D. M., Rosemond, E., Green, H. F., Liu, T., Chae, P. S., Dror, R. O., et al. (2012) · Nature · doi:10.1038/nature10867 · Cited by 811
Self-citationThe Dynamic Process of β2-Adrenergic Receptor Activation
Nygaard, R., Zou, Y., Dror, R. O., Mildorf, T. J., Arlow, D. H., Manglik, A., Pan, A. C., Liu, C. W., Fung, J. J., Bokoch, M. P., et al. (2013) · Cell · doi:10.1016/j.cell.2013.01.008 · Cited by 796
Self-citationStructure of the human M2 muscarinic acetylcholine receptor bound to an antagonist
Haga, K., Kruse, A. C., Asada, H., Yurugi-Kobayashi, T., Shiroishi, M., Zhang, C., Weis, W. I., Okada, T., Kobilka, B. K., Haga, T., et al. (2012) · Nature · doi:10.1038/nature10753 · Cited by 792
Self-citationWhorton, M. R., Bokoch, M. P., Rasmussen, S. G. F., Huang, B., Zare, R. N., Kobilka, B., & Sunahara, R. K. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0611448104 · Cited by 675
Self-citationCrystallizing membrane proteins using lipidic mesophases
Caffrey, M., & Cherezov, V. (2009) · Nature Protocols · doi:10.1038/nprot.2009.31 · Cited by 670
Crystal structure of metarhodopsin II
Choe, H.-W., Kim, Y. J., Park, J. H., Morizumi, T., Pai, E. F., Krauß, N., Hofmann, K. P., Scheerer, P., & Ernst, O. P. (2011) · Nature · doi:10.1038/nature09789 · Cited by 663
Muscarinic acetylcholine receptors: mutant mice provide new insights for drug development
Wess, J., Eglen, R. M., & Gautam, D. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2379 · Cited by 637
Self-citationBallesteros, J. A., Jensen, A. D., Liapakis, G., Rasmussen, S. G. F., Shi, L., Gether, U., & Javitch, J. A. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m103747200 · Cited by 619
Adrenaline-activated structure of β2-adrenoceptor stabilized by an engineered nanobody
Ring, A. M., Manglik, A., Kruse, A. C., Enos, M. D., Weis, W. I., Garcia, K. C., & Kobilka, B. K. (2013) · Nature · doi:10.1038/nature12572 · Cited by 491
Self-citationAllosteric GPCR modulators: taking advantage of permissive receptor pharmacology
Leach, K., Sexton, P. M., & Christopoulos, A. (2007) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2007.06.004 · Cited by 363
Self-citationEhlert, F. J. (1988) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)13145-3 · Cited by 351
β-Lactamase Inhibitors Derived from Single-Domain Antibody Fragments Elicited in the Camelidae
Conrath, K. E., Lauwereys, M., Galleni, M., Matagne, A., Frère, J.-M., Kinne, J., Wyns, L., & Muyldermans, S. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.10.2807-2812.2001 · Cited by 347
Kubo, T., Maeda, A., Sugimoto, K., Akiba, I., Mikami, A., Takahashi, H., Haga, T., Haga, K., Ichiyama, A., Kangawa, K., et al. (1986) · FEBS Letters · doi:10.1016/0014-5793(86)81144-9 · Cited by 343
Education reforms struggle against apartheid's legacy
(1996) · Nature · doi:10.1038/384014a0 · Cited by 291
Allosteric modulation of G protein-coupled receptors: A pharmacological perspective
Keov, P., Sexton, P. M., & Christopoulos, A. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2010.07.010 · Cited by 265
Self-citationStabilized G protein binding site in the structure of constitutively active metarhodopsin-II
Deupi, X., Edwards, P., Singhal, A., Nickle, B., Oprian, D., Schertler, G., & Standfuss, J. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1114089108 · Cited by 242
Activation and dynamic network of the M2 muscarinic receptor
Miao, Y., Nichols, S. E., Gasper, P. M., Metzger, V. T., & McCammon, J. A. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1309755110 · Cited by 217
Liu, J., Conklin, B. R., Blin, N., Yun, J., & Wess, J. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.25.11642 · Cited by 207
Self-citationGregory, K. J., Hall, N. E., Tobin, A. B., Sexton, P. M., & Christopoulos, A. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.094011 · Cited by 159
Self-citationThe Dynamic Process of b 2 -Adrenergic Receptor Activation
Nygaard, R., Zou, Y., Dror, R. O., Mildorf, T. J., Arlow, D. H., Manglik, A., Pan, A. C., Liu, C. W., Bokoch, M. P., Thian, F. S., et al. (2013) · Cited by 146
Self-citationThe allosteric vestibule of a seven transmembrane helical receptor controls G-protein coupling
Böck, A., Merten, N., Schrage, R., Dallanoce, C., Bätz, J., Klöckner, J., Schmitz, J., Matera, C., Simon, K., Kebig, A., et al. (2012) · Nature Communications · doi:10.1038/ncomms2028 · Cited by 140
Valant, C., Felder, C. C., Sexton, P. M., & Christopoulos, A. (2011) · Molecular Pharmacology · doi:10.1124/mol.111.074872 · Cited by 132
Self-citationA Monod-Wyman-Changeux Mechanism Can Explain G Protein-coupled Receptor (GPCR) Allosteric Modulation
Canals, M., Lane, J. R., Wen, A., Scammells, P. J., Sexton, P. M., & Christopoulos, A. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.314278 · Cited by 124
Self-citationAllosteric Modulation of Muscarinic Acetylcholine Receptors
Gregory, K. J., Sexton, P. M., & Christopoulos, A. (2007) · Current Neuropharmacology · doi:10.2174/157015907781695946 · Cited by 115
Self-citationAmici, M. D., Dallanoce, C., Holzgrabe, U., Tränkle, C., & Mohr, K. (2009) · Medicinal Research Reviews · doi:10.1002/med.20166 · Cited by 106
Wess, J., Maggio, R., Palmer, J. R., & Vogel, Z. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)41776-0 · Cited by 92
Self-citationStructural basis of G protein–coupled receptor–G protein interactions
Hu, J., Wang, Y., Zhang, X., Lloyd, J. R., Li, J. H., Karpiak, J. D., Costanzi, S., & Wess, J. (2010) · Nature Chemical Biology · doi:10.1038/nchembio.385 · Cited by 84
Self-citationAllosteric activators of muscarinic receptors as novel approaches for treatment of CNS disorders
Digby, G. J., Shirey-Rice, J. K., & Conn, P. J. (2010) · Molecular BioSystems · doi:10.1039/c002938f · Cited by 69
Structural Basis of M3 Muscarinic Receptor Dimer/Oligomer Formation
McMillin, S. M., Heusel, M., Liu, T., Costanzi, S., & Wess, J. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.259788 · Cited by 60
Self-citationPrilla, S., Schrobang, J., Ellis, J., Höltje, H., & Mohr, K. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.023481 · Cited by 59
Site-directed mutagenesis of the putative human muscarinic M2 receptor binding site
Heitz, F., Holzwarth, J. A., Gies, J., Pruss, R. M., Trumpp‐Kallmeyer, S., Hibert, M., & Guénet, C. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00439-2 · Cited by 51
The Third Intracellular Loop Stabilizes the Inactive State of the Neuropeptide Y1 Receptor
Chee, M. J. S., Mörl, K., Lindner, D., Merten, N., Zamponi, G. W., Light, P. E., Beck‐Sickinger, A. G., & Colmers, W. F. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m804671200 · Cited by 43
Structure/Activity Relationships of M 2 Muscarinic Allosteric Modulators
Mohr, K., Tränkle, C., & Holzgrabe, U. (2003) · Receptors and Channels · doi:10.3109/10606820308264 · Cited by 41
Hudgins, P. M., & STUBBINS, J. F. (1972) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)29277-1 · Cited by 18
Cited by
Molecular Dynamics Simulation for All
Hollingsworth, S. A., & Dror, R. O. (2018) · Neuron · doi:10.1016/j.neuron.2018.08.011 · Cited by 3,257
Roth, B. L. (2016) · Neuron · doi:10.1016/j.neuron.2016.01.040 · Cited by 1,742
The Molecular Basis of G Protein–Coupled Receptor Activation
Weis, W. I., & Kobilka, B. K. (2018) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-060614-033910 · Cited by 1,227
“49 with ICL2 as well as the end of TM2 is seen in several other active structures (32, 34).”
BackgroundMethodSelf-citationGPCRdb: an information system for G protein-coupled receptors
Isberg, V., Mordalski, S., Munk, C., Rataj, K., Harpsøe, K., Hauser, A. S., Vroling, B., Bojarski, A. J., Vriend, G., & Gloriam, D. E. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkv1178 · Cited by 1,072
Structural insights into µ-opioid receptor activation
Huang, W., Manglik, A., Venkatakrishnan, A. J., Laeremans, T., Feinberg, E. N., Sanborn, A. L., Kato, H. E., Livingston, K. E., Thorsen, T. S., Kling, R. C., et al. (2015) · Nature · doi:10.1038/nature14886 · Cited by 885
Self-citation
Metadata
- Authors
- Kruse, A. C., Ring, A. M., Manglik, A., Hu, J., Hu, K., Eitel, K., Hübner, H., Pardon, E., Valant, C., Sexton, P. M., Christopoulos, A., Felder, C. C., Gmeiner, P., Steyaert, J., Weis, W. I., Garcia, K. C., Wess, J., & Kobilka, B. K.
- Venue
- Nature
- Published
- 2013-11-20
- Volume
- 504
- Issue
- 7478
- Pages
- 101-106
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2051994079
- Cited by
- 893
- References
- 42
- FWCI
- 33.35
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.